Bin Fu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Urology top 5%
Papers in ⓘ
- Urology 17
- Urological Disorders and Treatments 13
-
- Renal cell carcinoma treatment 30
- Ferroptosis and cancer prognosis 21
- Prostate Cancer Diagnosis and Treatment 14
- Co-authors
- Wen Deng (43 shared papers)Xiaoqiang Liu (43 shared papers)Gongxian Wang (25 shared papers)Luyao Chen (40 shared papers)Bin Lang (15 shared papers)Xin Ma (14 shared papers)Ailing Fu (2 shared papers)Hongzhao Li (10 shared papers)
- Journals
- Frontiers in Oncology (19 papers)Journal of Endourology (7 papers)The Journal of Urology (6 papers)Frontiers in Immunology (5 papers)Journal of Oncology (5 papers)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Bin Fu
157 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 134
- Cancer Research 449
- Urology 137
- Pulmonary and Respiratory Medicine 510
- Endocrinology, Diabetes and Metabolism 229
- Surgery 607
Countries citing papers authored by Bin Fu
This map shows the geographic impact of Bin Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Fu more than expected).
Fields of papers citing papers by Bin Fu
This network shows the impact of papers produced by Bin Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Fu. The network helps show where Bin Fu may publish in the future.
Co-authors
The 25 scholars most cited alongside Bin Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 173 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 114 | |
| 2 | 2020 | 92 | |
| 3 | 2007 | 70 | |
| 4 | 2017 | 60 | |
| 5 | 2006 | 59 | |
| 6 | 2011 | 59 | |
| 7 | miR-451 inhibits invasion and proliferation of bladder cancer by regulating EMT. | 2014 | 50 |
| 8 | 2015 | 49 | |
| 9 | 2018 | 42 | |
| 10 | 2007 | 40 | |
| 11 | 2021 | 38 | |
| 12 | 2007 | 38 | |
| 13 | 2019 | 36 | |
| 14 | 2021 | 35 | |
| 15 | 2005 | 35 | |
| 16 | 2019 | 34 | |
| 17 | 2020 | 33 | |
| 18 | 2021 | 32 | |
| 19 | 2011 | 32 | |
| 20 | 2015 | 31 |
About Bin Fu
Bin Fu is a scholar working on Urology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Molecular Biology, having authored 173 papers that have together received 2.1k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (41 papers), Renal cell carcinoma treatment (30 papers), Ferroptosis and cancer prognosis (21 papers), Urinary and Genital Oncology Studies (19 papers), Renal and related cancers (17 papers), Prostate Cancer Diagnosis and Treatment (14 papers), Epigenetics and DNA Methylation (13 papers) and Urological Disorders and Treatments (13 papers). The work is most often cited by research in Cancer Research (449 citations), Urology (137 citations), Pulmonary and Respiratory Medicine (510 citations), Endocrinology, Diabetes and Metabolism (229 citations) and Surgery (607 citations). Bin Fu has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Wen Deng, Xiaoqiang Liu, Gongxian Wang, Luyao Chen, Bin Lang, Xin Ma, Ailing Fu, Hongzhao Li, Jun Zhang and Kai Xu. Their work appears in journals such as Frontiers in Oncology, Journal of Endourology, The Journal of Urology, Frontiers in Immunology and Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.